Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

January 7, 2022

Conditions
Methamphetamine Abuse
Interventions
BEHAVIORAL

Affect Methamphetamine Treatment Program

"Components of the treatment services include: contingency management (CM; monetary incentives for drug tests negative for stimulants), the digital behavioral therapy curriculum (based on CBT) delivered via the Affect app on smartphones, weekly one-on-one telemedicine (TM) with clinical personnel and group therapy, and referral to psychiatrist for medication support, as needed. The program incrementally builds skills and beliefs to develop personally meaningful strategies to combat cravings, using such techniques as regular app-promoted deep breathing exercises, daily exercise, and help in making and sticking to a relapse prevention plan. Counseling sessions are arranged via text sent by the Team Care advocate and also presented to the participant via the app as a reminder. Individual and group therapy sessions occur over Zoom, which is integrated into the app.~Contingency Management (CM). CM utilizes monetary incentives and rewards to promote behavior change."

Trial Locations (1)

10012

Affect Therapeutics, New York

Sponsors
All Listed Sponsors
lead

Affect Therapeutics, Inc.

INDUSTRY